resource-symbol

Childhood Asthma Control Test (C-ACT)

GlaxoSmithKline Research & Development Limited

Distributed by Mapi Research Trust

Distributed by Mapi Research Trust

default distrib
 

Basic description

Please note that the Adult ACT is owned and controlled by QualityMetric/Optum.

The C-ACT can be valuable in clinical practice and research based on its validation, ease of use, input from the child and caregiver, and alignment with asthma guidelines.

Authors

GlaxoSmithKline Research & Development Limited

Copyright
C-ACT © 2007 GSK group of companies. All Rights Reserved.
Objective
To assess asthma control in children 4-11 years old
Therapeutic area
  • Respiratory Tract Diseases
  • Bacterial Infections and Mycoses
  • Immune System Diseases
Therapeutic indication
  • Respiratory Tract Infections
  • Asthma
Type of Clinical Outcome Assessment (COA)
  • Composite measures Composite measures
PRO and ObsRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, Rosenzweig JC, Manjunath R. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol. 2007 Apr;119(4):817-25 (Full text article)

Liu AH, Zeiger RS, Sorkness CA, Ostrom NK, Chipps BE, Rosa K, Watson ME, Kaplan MS, Meurer JR, Mahr TA, Blaiss MS, Piault-Louis E, McDonald J. The Childhood Asthma Control Test: retrospective determination and clinical validation of a cut point to identify children with very poorly controlled asthma. J Allergy Clin Immunol. 2010 Aug;126(2):267-73, 273.e1 (Full text article)


Contact and conditions of use

Authors

GlaxoSmithKline Research & Development Limited

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Non-Commercial Users

If you do not receive specific funding for your study, you may download the questionnaire directly:

  1. Log in or Register for free
  2. Click the 'Online distribution' tab in the left menu bar and follow the instructions

Tutorials are available on our FAQs.

Commercial Users

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. In order to accelerate the process, you may attach the User Agreement (even if not finalized) to your online request. Click the link below for the user agreement template.
  4. Our PROVIDE team will get back to you with the needed information in a timely manner

Access fees

DISTRIBUTION FEES* Commercial users Cost per study 1 000 €
Cost per language 500 €
Funded academic research Cost per study Free
Cost per language Free
Not funded academic users Cost per study Free
Cost per language Free

It should be noted that the C-ACT is free from any royalty fee requested by the Owner, GlaxoSmithKline Research & Development Limited.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Online distribution

For Non-Funded Academic Studies

The following licensing process is restricted to academic users:

  • Who do not receive specific funding for their study
  • Who intend to use the questionnaire in individual clinical practice or research study

Should you not correspond to this category of users, please send us a request.

Note: This site aims at providing you with the original version and existing translations of the questionnaire. However some modules/versions may not be downloadable in the language you need.

If you are interested in specific language(s), please first consult the list of existing translations in PROQOLID.

Login

To access this section, please complete a client account.

Languages

Original language(s)

  • English for the USA

Translations

The translations listed may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

C-ACT

Afrikaans for South Africa*
Arabic for Egypt*
Arabic for Saudi Arabia*
Cantonese for Hong Kong*
Croatian for Croatia*
Czech for Czech Republic*
Danish for Denmark*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for Australia*
English for Canada*
English for South Africa*
English for the UK*
Finnish for Finland*
French for Belgium*
French for Canada*
French for France*
German for Austria*
German for Germany*
German for Switzerland*
Greek for Greece*
Hungarian for Hungary*
Italian for Italy*
Japanese for Japan*
Korean for South Korea*
Lithuanian for Lithuania*
Mandarin for China*
Mandarin for Taiwan*
Norwegian for Norway*
Polish for Poland*
Portuguese for Brazil*
Portuguese for Portugal*
Romanian for Romania*
Russian for Russia*
Sesotho for South Africa*
Slovak for Slovakia*
Slovenian for Slovenia*
Spanish for Argentina*
Spanish for Colombia
Spanish for Mexico*
Spanish for Puerto Rico*
Spanish for Spain*
Spanish for the USA*
Swedish for Sweden*
Thai for Thailand*
Turkish for Turkey*
Urdu for Pakistan*
Xhosa for South Africa*
Zulu for South Africa*
* Performed by Mapi

Conditions to translate

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

More information on translations

Bibliographic reference of the Brazilian Portuguese version:

Oliveira SG, Sarria EE, Roncada C, Stein RT, Pitrez PM, Mattiello R. Validation of the Brazilian version of the childhood asthma control test (c-ACT). Pediatr Pulmonol. 2016 Apr;51(4):358-63 (PubMed abstract

Bibliographic reference of the Chinese version (for Taiwan):

Chen HH, Wang JY, Jan RL, Liu YH, Liu LF. Reliability and validity of childhood asthma control test in a population of Chinese asthmatic children. Qual Life Res. 2008 May;17(4):585-93 (PubMed abstract)

Bibliographic reference of the Spanish version (for Colombia):

Rodríguez-Martínez CE, Melo-Rojas A, Restrepo-Gualteros SM, Sossa-Briceño MP, Nino G. Validation of the Spanish version of the childhood asthma control test (cACT) in a population of Hispanic children. J Asthma. 2014 Oct;51(8):855-62 (PubMed abstract)

Bibliographic reference of the Spanish version (for Spain):

Pérez-Yarza EG, Castro-Rodriguez JA, Villa Asensi JR, Garde Garde J, Hidalgo Bermejo FJ; Grupo VESCASI.. [Validation of a Spanish version of the Childhood Asthma Control Test (Sc-ACT) for use in Spain]. An Pediatr (Barc). 2015 Aug;83(2):94-103 (PubMed abstract)

Bibliographic reference of the Turkish version:

Sekerel BE, Soyer OU, Keskin O, Uzuner N, Yazicioglu M, Kiliç M, Artaç H, Ozmen S, Can D, Zeyrek D, Cokugras H, Canitez Y, Aydogan M, Kuyucu S, Inal A, Gurkan F, Orhan F, Yilmaz O, Boz AB, Tahan F, Cevit O. The reliability and validity of Turkish version of Childhood Asthma Control Test. Qual Life Res. 2012 May;21(4):685-90 (PubMed abstract)

Last update: November 2017
For additional information, please submit a request. More information in our FAQs.